Michelle Durborow with Rodrigo Salas, LRG board member, at tenth annual ICORD meeting. The tenth annual ICORD meeting was held in Mexico City on October 13-14 with the theme “A Decade of Discoveries and [...]
LRG research team member, Dr. Sebastian Bauer recently received the 6th Annual Science Prize awarded by the GIST Group Switzerland on November 26, 2015 at the semi-annual meeting of the Swiss Group for Clinical [...]
The National Organization for Rare Diseases (NORD) held its 2015 Breakthrough Summit October 21-22 in Arlington, Virginia. This year’s event convened top leaders from the FDA, NIH, Industry, Patient Groups, Payers and Research Institutions to [...]
Executive Director, Norman Scherzer participated in a panel discussion as part of the Executive Vision Forum Series hosted by Quintiles Advisory Services on Friday, November 6 in the Alexandria Center, NYC.The panel, entitled “Working within [...]
I met Ian Rahimi today. I knew that going to his funeral would give me an opportunity to pay my respects to Ian and his family and to mourn his passing. I knew that [...]
Cancerversary - 19 YEARS Chuck Korte “It is a blessing to be alive; we can give thanks by being a blessing to others” If you have a Cancerversary, let us know. Contact us at liferaft@liferaftgroup.org and we [...]
The 7th Annual Partnering for Cures meeting hosted by FasterCures was held Nov. 1-3 in NYC with more than 750 movers and shakers from patient groups, pharma, academia, government and industry. Some notable participants included: [...]
A recent study further documented the advantage of three years of adjuvant imatinib versus one year in high-risk GIST patients. The study, which is to be published in the Journal of Clinical Oncology, was authored by [...]
It has been a long journey since that day Melinda and I walked out of my Dallas oncologist’s office in May, 2000 knowing that I had a rare, then untreatable cancer. Now, it has [...]
Immunotherapy is a promising area in cancer research and in emerging treatments. Several new studies highlight the role that gut microbes may play in the efficacy of immunotherapy treatments.In a recent article in the Atlantic, [...]
